Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants

Serological tests are beneficial for recognizing the immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity, optimization of the chemiluminescent reduction neutralizing test (CRNT) is critical. Whether commercial antibody tests have comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Morinaga, Yoshitomo, Tani, Hideki, Terasaki, Yasushi, Nomura, Satoshi, Kawasuji, Hitoshi, Shimada, Takahisa, Igarashi, Emiko, Saga, Yumiko, Yoshida, Yoshihiro, Yasukochi, Rei, Kaneda, Makito, Murai, Yushi, Ueno, Akitoshi, Miyajima, Yuki, Fukui, Yasutaka, Nagaoka, Kentaro, Ono, Chikako, Matsuura, Yoshiharu, Fujimura, Takashi, Ishida, Yoichi, Oishi, Kazunori, Yamamoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635131/
https://www.ncbi.nlm.nih.gov/pubmed/34851163
http://dx.doi.org/10.1128/Spectrum.00560-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635131/
https://www.ncbi.nlm.nih.gov/pubmed/34851163
http://dx.doi.org/10.1128/Spectrum.00560-21

Ejemplares similares